Clinical Trial Update: Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery [NA]

View source ↗

Summary

A clinical trial update reports that bosentan may improve clinical outcomes in adults with congenital heart disease or mitral valve lesions undergoing cardiac s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Mitral Valve Disease

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Berto J Bouma | Conditions: Congenital Heart Disease | NA | Status: UNKNOWN